These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9284631)
1. Combined effect of Web 2086 (Paf antagonist) and ketoprofen (Nsaid) on Paf-induced ex vivo platelet aggregation in bovine. Bastos da Silva M; Herion F; Raskinet R; David JL; Gustin P; Lekeux P Zentralbl Veterinarmed A; 1997 Apr; 44(2):65-71. PubMed ID: 9284631 [TBL] [Abstract][Full Text] [Related]
2. The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves. Bastos da Silva MB; Gustin P; Herion F; Raskinet R; David JL; Gougnard T; Plomteux G; Desmecht D; Lekeux P Vet Res Commun; 1997 Oct; 21(7):521-31. PubMed ID: 9345719 [TBL] [Abstract][Full Text] [Related]
3. Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves. da Silva MB; Dessy C; Coghe J; David JL; Lekeux P Vet Res Commun; 1998 Jun; 22(4):273-91. PubMed ID: 9686442 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine. da Silva MB; Herion F; Raskinet R; David JL; Gustin P; Dessy C; Lekeux P Zentralbl Veterinarmed A; 1996 Sep; 43(7):399-413. PubMed ID: 8921726 [TBL] [Abstract][Full Text] [Related]
5. Effect of ketoprofen on PAF-induced bovine platelet aggregation. da Silva MB; Gustin P; Herion F; David JL; Van de Weerdt ML; Lekeux P Vet J; 1998 Mar; 155(2):201-3. PubMed ID: 9564275 [No Abstract] [Full Text] [Related]
6. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914 [TBL] [Abstract][Full Text] [Related]
7. Morphological alterations of blood platelets induced by platelet activating factor (PAF) and partial inhibition by ketoprofen in calves. Bastos da Silva M; Dessy C; David JL; Lekeux P Vet Res; 1997; 28(5):489-502. PubMed ID: 9342825 [TBL] [Abstract][Full Text] [Related]
8. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Foster AP; Lees P; Andrews MJ; Cunningham FM Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors. Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse. Foster AP; Cunningham FM; Andrews MJ; Lees P J Vet Pharmacol Ther; 1993 Dec; 16(4):477-87. PubMed ID: 8126765 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331 [TBL] [Abstract][Full Text] [Related]
12. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation. Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man. Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787 [TBL] [Abstract][Full Text] [Related]
14. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers. Adamus WS; Heuer H; Meade CJ Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341 [TBL] [Abstract][Full Text] [Related]
15. Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood. Chan WP; Levy JV Prostaglandins; 1991 Oct; 42(4):337-42. PubMed ID: 1665568 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo. Yue TL; Rabinovici R; Farhat M; Feuerstein G J Lipid Mediat; 1991; 3(1):13-26. PubMed ID: 1768837 [TBL] [Abstract][Full Text] [Related]
18. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772 [TBL] [Abstract][Full Text] [Related]
19. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Grigoriadis G; Stewart AG Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761 [TBL] [Abstract][Full Text] [Related]
20. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. Saeed SA; Rasheed H Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]